Is CTI BioPharma Corp. (CTIC) a Buy, Sell, or Hold?
NASDAQ : CTIC
CTI BioPharma Corp. — Institutional Ownership
$9.095 USD
$0.01 (0.06%)
- Volume
- 5.56M
- Average Volume
- 6.36M
- Market Capitalization
- $1.2B
- P/E Ratio
- -11.51
- Dividend Yield
- 0.00%
- Price Target
- $9.00
- Year High
- $9.10
- Year Low
- $4.01
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.23
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2023-04-13 | Jon M. Plexico | 7.02M | 11.00% |
| 2023-04-13 | Stonepine Capital, L.P. | 7.02M | 11.00% |
| 2023-04-13 | Stonepine Capital Management, LLC | 7.02M | 11.00% |
| 2023-03-24 | Timothy P. Lynch | 7M | 11.00% |
| 2023-02-03 | (1) BlackRock, Inc. | 7.06M | 5.60% |
| 2022-06-17 | W. Sonsini | 9.61M | 8.80% |
| 2022-06-17 | D. Sandell | 9.61M | 8.80% |
| 2022-06-17 | Partners 16, L.P. | 9.61M | 8.80% |
| 2022-06-17 | H. Makhzoumi | 9.61M | 8.80% |
| 2022-06-17 | A. Florence, Jr. | 9.61M | 8.80% |
| 2022-06-17 | Behbahani | 9.61M | 8.80% |
| 2022-06-17 | Baskett | 9.61M | 8.80% |
| 2022-06-17 | 16 GP, LLC | 9.61M | 8.80% |
| 2022-06-17 | Walker | 9.61M | 8.80% |
| 2022-06-17 | Equity Opportunities Fund V, LLC | 9.61M | 8.80% |
| 2022-06-17 | Enterprise Associates 16, L.P. | 9.61M | 8.80% |
| 2022-06-17 | Chang | 9.61M | 8.80% |
| 2022-06-13 | Millennium Management LLC | 5.94M | 5.50% |
| 2022-06-13 | Millennium Group Management LLC | 5.94M | 5.50% |
| 2022-06-13 | Israel A. Englander | 5.94M | 5.50% |
| 2022-02-14 | Caxton Corporation | 2.24M | 2.30% |
| 2022-02-14 | CDK Trading, LLC | 2.24M | 2.30% |
| 2022-02-14 | Bruce S. Kovner | 2.24M | 2.30% |
| 2022-02-14 | Timothy P. Lynch | 9.75M | 11.00% |
| 2022-02-14 | Stonepine Capital, L.P. | 9.75M | 11.00% |
| 2022-02-14 | Jon M. Plexico | 9.75M | 11.00% |
| 2022-02-14 | Stonepine Capital Management, LLC | 9.75M | 11.00% |
| 2021-12-06 | OrbiMed Capital GP VI LLC | 4.02M | 4.00% |
| 2021-03-15 | BVF INC. | 17.12M | 19.99% |
| 2021-03-15 | BVF PARTNERS L.P. | 17.12M | 19.99% |
| 2021-03-15 | BIOTECHNOLOGY VALUE TRADING FUND OS LP | 1.17M | 1.50% |
| 2021-03-15 | BVF GP HOLDINGS LLC | 13.14M | 16.40% |
| 2021-03-15 | BVF PARTNERS OS LTD. | 1.17M | 1.50% |
| 2021-03-15 | BIOTECHNOLOGY VALUE FUND, L.P. | 8.61M | 10.60% |
| 2021-03-15 | BVF I GP LLC | 8.61M | 10.60% |
| 2021-03-15 | BIOTECHNOLOGY VALUE FUND II, L.P. | 4.54M | 5.80% |
| 2021-03-15 | BVF II GP LLC | 4.54M | 5.80% |
| 2021-03-15 | MATTHEW D. PERRY | 353.14K | 1.00% |
| 2021-03-15 | MARK N. LAMPERT | 17.12M | 19.99% |
| 2021-02-16 | CDK Trading, LLC | 3.75M | 5.10% |
| 2021-02-16 | Bruce S. Kovner | 3.75M | 5.10% |
| 2021-02-16 | Caxton Corporation | 3.75M | 5.10% |
| 2021-02-12 | Stonepine Capital Management, LLC | 8.15M | 11.00% |
| 2021-02-12 | Timothy P. Lynch | 8.15M | 11.00% |
| 2021-02-12 | Jon M. Plexico | 8.15M | 11.00% |
| 2021-02-12 | Stonepine Capital, L.P. | 8.15M | 11.00% |
| 2020-10-02 | Caxton Corporation | 4.49M | 6.10% |
| 2020-03-12 | Forest Baskett | 7.38M | 9.99% |
| 2020-03-12 | Carmen Chang | 7.38M | 9.99% |
| 2020-03-12 | Ali Behbahani | 7.38M | 9.99% |
| 2020-03-12 | Anthony A. Florence, Jr. | 7.38M | 9.99% |
| 2020-03-12 | H. Makhzoumi | 7.38M | 9.99% |
| 2020-03-12 | Joshua Makower | 7.38M | 9.99% |
| 2020-03-12 | Scott D. Sandell | 7.38M | 9.99% |
| 2020-03-12 | Peter W. Sonsini | 7.38M | 9.99% |
| 2020-03-12 | Paul Walker | 7.38M | 9.99% |
| 2020-03-12 | Partners 16, L.P. | 7.38M | 9.99% |
| 2020-03-12 | NEA 16 GP, LLC | 7.38M | 9.99% |
| 2020-03-12 | New Enterprise Associates 16, L.P. | 7.38M | 9.99% |
| 2020-03-12 | Equity Opportunities Fund V, LLC | 7.38M | 9.99% |
| 2020-03-10 | OrbiMed Advisors LLC | 9.52M | 12.90% |
| 2020-03-10 | OrbiMed Capital GP VI LLC | 9.52M | 12.90% |
| 2020-03-04 | BIOTECHNOLOGY VALUE TRADING FUND OS LP | 483.71K | 1.00% |
| 2020-03-04 | BVF GP HOLDINGS LLC | 10.97M | 17.20% |
| 2020-03-04 | BVF II GP LLC | 4.18M | 7.00% |
| 2020-03-04 | BVF PARTNERS OS LTD. | 483.71K | 1.00% |
| 2020-03-04 | MARK N. LAMPERT | 12.75M | 19.99% |
| 2020-03-04 | BVF INC. | 12.75M | 19.99% |
| 2020-03-04 | BVF PARTNERS L.P. | 12.75M | 19.99% |
| 2020-03-04 | BIOTECHNOLOGY VALUE FUND, L.P. | 6.8M | 11.00% |
| 2020-03-04 | BVF I GP LLC | 6.8M | 11.00% |
| 2020-03-04 | MATTHEW D. PERRY | 153.14K | 1.00% |
| 2020-03-04 | BIOTECHNOLOGY VALUE FUND II, L.P. | 4.18M | 7.00% |
| 2020-02-13 | Stonepine Capital Management, LLC | 3.61M | 11.00% |
| 2020-02-13 | Forest Baskett | 3.75M | 6.50% |
| 2020-02-13 | NEA 16 GP, LLC | 3.75M | 6.50% |
| 2020-02-13 | NEA Partners 16, L.P. | 3.75M | 6.50% |
| 2020-02-13 | New Enterprise Associates 16, L.P. | 3.75M | 6.50% |
| 2020-02-13 | Paul Walker | 3.75M | 6.50% |
| 2020-02-13 | Growth Equity Opportunities Fund V, LLC | 3.75M | 6.50% |
| 2020-02-13 | Stonepine Capital, L.P. | 3.61M | 11.00% |
| 2020-02-13 | Jon M. Plexico | 3.61M | 11.00% |
| 2020-02-13 | Timothy P. Lynch | 3.61M | 11.00% |
| 2020-02-13 | Ali Behbahani | 3.75M | 6.50% |
| 2020-02-13 | Carmen Chang | 3.75M | 6.50% |
| 2020-02-13 | Anthony A. Florence, Jr. | 3.75M | 6.50% |
| 2020-02-13 | Mohamad H. Makhzoumi | 3.75M | 6.50% |
| 2020-02-13 | Joshua Makower | 3.75M | 6.50% |
| 2020-02-13 | Scott D. Sandell | 3.75M | 6.50% |
| 2020-02-13 | Peter W. Sonsini | 3.75M | 6.50% |
| 2020-02-04 | BVF GP HOLDINGS LLC | 10.97M | 17.20% |
| 2020-02-04 | BVF PARTNERS OS LTD. | 483.71K | 1.00% |
| 2020-02-04 | BVF II GP LLC | 4.18M | 7.00% |
| 2020-02-04 | BIOTECHNOLOGY VALUE TRADING FUND OS LP | 483.71K | 1.00% |
| 2020-02-04 | BVF I GP LLC | 6.8M | 11.00% |
| 2020-02-04 | BVF INC. | 12.75M | 19.99% |
| 2020-02-04 | BVF PARTNERS L.P. | 12.75M | 19.99% |
| 2020-02-04 | BIOTECHNOLOGY VALUE FUND, L.P. | 6.8M | 11.00% |
| 2020-02-04 | BIOTECHNOLOGY VALUE FUND II, L.P. | 4.18M | 7.00% |
| 2020-02-04 | MARK N. LAMPERT | 12.75M | 19.99% |
| 2020-02-04 | MATTHEW D. PERRY | 153.14K | 1.00% |
| 2019-02-13 | Jon M. Plexico | 5.73M | 11.00% |
| 2019-02-13 | Timothy P. Lynch | 5.73M | 11.00% |
| 2019-02-13 | Stonepine Capital Management, LLC | 5.73M | 11.00% |
| 2019-02-13 | Stonepine Capital, L.P. | 4.62M | 11.00% |
| 2018-02-05 | Baxalta GmbH | - | 0.00% |
| 2018-02-05 | Baxalta Incorporated | - | 0.00% |
| 2018-02-05 | Shire plc | - | 0.00% |
| 2018-01-12 | information which would alter the disclosures provided in a prior cover page. | 2.15M | 11.00% |
| 2017-06-22 | Stonepine Capital, L.P. | 2.31M | 11.00% |
| 2017-06-22 | Jon M. Plexico | 2.31M | 11.00% |
| 2017-06-22 | Stonepine Capital Management, LLC | 2.31M | 11.00% |
| 2017-06-22 | Timothy P. Lynch | 2.31M | 11.00% |
| 2017-06-15 | Samuel D. Isaly | 5M | 11.60% |
| 2017-06-15 | OrbiMed Capital GP VI LLC | 5M | 11.60% |
| 2017-06-15 | OrbiMed Advisors LLC | 5M | 11.60% |
| 2017-02-06 | Baxalta Incorporated | 1.57M | 5.50% |
| 2017-02-06 | Shire plc | 1.57M | 5.50% |
| 2017-02-06 | Baxalta GmbH | 1.57M | 5.50% |
| 2017-01-31 | NB Public Equity K/S | 13.57M | 4.80% |
| 2017-01-31 | NB Public Equity Komplementar ApS | 13.57M | 4.80% |
| 2017-01-31 | Cora Madsen | 13.57M | 4.80% |
| 2017-01-31 | Florian Schönharting | 13.57M | 4.80% |
| 2016-06-07 | Baxalta GmbH | 15.67M | 5.50% |
| 2016-06-07 | Shire plc | 15.67M | 5.50% |
| 2016-06-07 | Baxalta Incorporated | 15.67M | 5.50% |
| 2016-04-11 | Abigail P. Johnson | 24.66M | 8.76% |
| 2016-04-11 | Select Biotechnology Portfolio | 19.93M | 7.08% |
| 2016-04-11 | FMR LLC | 24.66M | 8.76% |
| 2016-02-29 | 6.8% (2)(3) | 15.67M | 6.80% |
| 2016-02-29 | 6.8% (2)(3) | 15.67M | 6.80% |
| 2016-02-10 | (1) BlackRock, Inc. | 12.69M | 4.50% |
| 2016-01-29 | Cora Madsen | 12.67M | 5.50% |
| 2016-01-29 | NB Public Equity Komplementar ApS | 12.67M | 5.50% |
| 2016-01-29 | Florian Schönharting | 12.67M | 5.50% |
| 2016-01-29 | NB Public Equity K/S | 12.67M | 5.50% |
| 2016-01-28 | (1) BlackRock, Inc. | 11.82M | 5.10% |
| 2016-01-14 | BVF PARTNERS L.P. | 44.8M | 15.90% |
| 2016-01-14 | BVF PARTNERS OS LTD. | 3.09M | 1.10% |
| 2016-01-14 | MATTHEW D. PERRY | - | 0.00% |
| 2016-01-14 | BVF INC. | 44.8M | 15.90% |
| 2016-01-14 | BIOTECHNOLOGY VALUE FUND, L.P. | 15.59M | 5.50% |
| 2016-01-14 | MARK N. LAMPERT | 44.8M | 15.90% |
| 2016-01-14 | BIOTECHNOLOGY VALUE FUND II, L.P. | 8.85M | 3.10% |
| 2016-01-14 | BIOTECHNOLOGY VALUE TRADING FUND OS LP | 3.09M | 1.10% |
| 2016-01-11 | BIOTECHNOLOGY VALUE FUND, L.P. | 15.59M | 5.50% |
| 2016-01-11 | BIOTECHNOLOGY VALUE FUND II, L.P. | 8.85M | 3.10% |
| 2016-01-11 | BVF PARTNERS OS LTD. | 3.09M | 1.10% |
| 2016-01-11 | BIOTECHNOLOGY VALUE TRADING FUND OS LP | 3.09M | 1.10% |
| 2016-01-11 | BVF PARTNERS L.P. | 44.8M | 15.90% |
| 2016-01-11 | BVF INC. | 44.8M | 15.90% |
| 2016-01-11 | MARK N. LAMPERT | 44.8M | 15.90% |
| 2015-12-11 | BIOTECHNOLOGY VALUE TRADING FUND OS LP | 3.03M | 1.10% |
| 2015-12-11 | BIOTECHNOLOGY VALUE FUND II, L.P. | 8.67M | 3.10% |
| 2015-12-11 | MARK N. LAMPERT | 43.8M | 15.50% |
| 2015-12-11 | BVF PARTNERS OS LTD. | 3.03M | 1.10% |
| 2015-12-11 | BVF PARTNERS L.P. | 43.8M | 15.50% |
| 2015-12-11 | BVF INC. | 43.8M | 15.50% |
| 2015-12-11 | BIOTECHNOLOGY VALUE FUND, L.P. | 14.9M | 5.30% |
| 2015-12-10 | (1) BlackRock, Inc. | 10.18M | 4.40% |
| 2015-12-07 | BVF Inc. | 43.8M | 15.50% |
| 2015-12-07 | Mark N. Lampert | 43.8M | 15.50% |
| 2015-12-07 | BVF Partners L.P. | 43.8M | 15.50% |
| 2015-12-07 | MSI BVF SPV, LLC | 5.37M | 1.90% |
| 2015-12-07 | Investment 10, L.L.C. | 2.73M | 1.00% |
| 2015-12-07 | Biotechnology Value Fund, L.P. | 14.9M | 5.30% |
| 2015-12-07 | Biotechnology Value Fund II, L.P. | 8.67M | 3.10% |
| 2015-12-07 | Biotechnology Value Trading Fund OS LP | 3.03M | 1.10% |
| 2015-12-07 | BVF Partners OS Ltd. | 3.03M | 1.10% |
| 2015-11-10 | FMR LLC | 28.8M | 13.90% |
| 2015-10-02 | MSI BVF SPV, LLC | 1.43M | 1.00% |
| 2015-10-02 | Mark N. Lampert | 10M | 5.20% |
| 2015-10-02 | BVF Inc. | 10M | 5.20% |
| 2015-10-02 | Biotechnology Value Fund II, L.P. | 2.8M | 1.50% |
| 2015-10-02 | BVF Partners L.P. | 10M | 5.20% |
| 2015-10-02 | Biotechnology Value Fund, L.P. | 4.88M | 2.60% |
| 2015-10-02 | Investment 10, L.L.C. | 892.81K | 1.00% |
| 2015-06-08 | 59-2385219 | 972.42K | 0.54% |
| 2015-05-01 | 8.7%(2) | 15.67M | 8.70% |
| 2015-05-01 | 2. | - | 0.00% |
| 2015-05-01 | 2. | 15.67M | 8.70% |
| 2015-05-01 | 8.7%(2) | 15.67M | 8.70% |
| 2015-02-13 | Abigail P. Johnson | 4.28M | 2.41% |
| 2015-02-13 | Edward C. Johnson 3d | 4.28M | 2.41% |
| 2015-02-13 | FMR LLC | 4.28M | 2.41% |
| 2015-02-02 | (1) BlackRock, Inc. | 9.74M | 5.50% |
| 2015-01-07 | 59-2385219 | 12.71M | 7.20% |
| 2014-01-28 | (1) BlackRock, Inc. | 8.65M | 5.90% |
| 2013-11-25 | 10.8 % (2) | 15.67M | 10.80% |
| 2013-11-25 | 10.8 % (2) | 15.67M | 10.80% |
| 2013-02-14 | TANG CAPITAL PARTNERS, LP | - | 0.00% |
| 2013-02-14 | Edward C. Johnson 3d | 8.04M | 8.21% |
| 2013-02-14 | FMR LLC | 8.04M | 8.21% |
| 2013-02-14 | KEVIN C. TANG | - | 0.00% |
| 2013-02-14 | TANG CAPITAL MANAGEMENT, LLC | - | 0.00% |
| 2012-11-13 | Edward C. Johnson 3d | 8.03M | 12.84% |
| 2012-11-13 | FMR LLC | 8.03M | 12.84% |
| 2012-10-09 | TANG CAPITAL MANAGEMENT, LLC | 6.91M | 9.90% |
| 2012-10-09 | KEVIN C. TANG | 6.91M | 9.90% |
| 2012-10-09 | TANG CAPITAL PARTNERS, LP | 6.91M | 9.90% |
| 2011-01-24 | 27-1051956 | 87.03M | 9.70% |
| 2011-01-24 | N/A | 87.03M | 9.70% |
| 2011-01-24 | 27-0901060 | 87.03M | 9.70% |
| 2011-01-24 | S. Peizer | 87.03M | 9.70% |
| 2011-01-24 | Peizer | 87.03M | 9.70% |
| 2008-10-06 | Mitchell S. Levine | 2.05M | 9.99% |
| 2008-10-06 | Enable Growth Partners, L.P. | 2.05M | 9.99% |
| 2008-10-06 | Enable Capital Management, LLC | 2.05M | 9.99% |
| 2008-10-06 | Mitchell S. Levine | 2.05M | 9.99% |
| 2008-10-06 | Enable Capital Management, LLC | 2.05M | 9.99% |
| 2008-10-06 | Enable Growth Partners, L.P. | 2.05M | 9.99% |
| 2008-08-25 | 98-0338449 | 25200.0 | 0.00% |
| 2008-08-25 | N/A | 25200.0 | 0.00% |
| 2008-08-25 | N/A | 25200.0 | 0.00% |
| 2008-08-25 | 52-2038706 | 25200.0 | 0.00% |
| 2008-08-25 | 13-2518466 | 1600.0 | 0.00% |
| 2008-08-25 | 22-3335453 | 25200.0 | 0.00% |
| 2008-08-25 | 13-3216325 | 26800.0 | 0.00% |
| 2008-05-12 | Ross Berman | 10.5M | 9.99% |
| 2008-05-12 | BAM Capital, LLC | 10.5M | 9.99% |
| 2008-05-12 | BAM Opportunity Fund, L.P. | 10.5M | 9.99% |
| 2008-05-12 | Hal Mintz | 10.5M | 9.99% |
| 2006-02-15 | Siu Min Wong | 7.57M | 9.50% |
| 2006-02-15 | Linden Capital LP | 7.57M | 9.50% |
| 2005-03-23 | Steeler Fund, Ltd. | - | 0.00% |
| 2005-03-23 | Duquesne Capital Management, L.L.C. | 200K | 0.30% |
| 2005-03-23 | Stanley F. Druckenmiller | 200K | 0.30% |
| 2005-02-01 | Steeler Fund, Ltd. | 3.09M | 5.00% |
| 2005-02-01 | Stanley F. Druckenmiller | 4.21M | 6.80% |
| 2005-02-01 | Duquesne Capital Management, L.L.C. | 4.21M | 6.80% |
| 2004-08-03 | (. | 2.54M | 11.00% |
| 2004-07-07 | (. | 2.54M | 11.00% |
| 2004-04-16 | ARIES SELECT I LLC | 293.47K | 0.58% |
| 2004-04-16 | PARAMOUNT CAPITAL ASSET MANAGEMENT, INC. | 822.3K | 1.63% |
| 2004-04-16 | ARIES SELECT, LTD. | 465.16K | 0.92% |
| 2004-04-16 | ARIES SELECT II LLC | 63632.0 | 0.13% |
| 2004-04-16 | LINDSAY A. ROSENWALD, M.D. | 2.4M | 4.76% |
| 2004-02-12 | ARIES SELECT, LTD. | 663.89K | 1.33% |
| 2004-02-12 | ARIES SELECT II LLC | 100.03K | 0.20% |
| 2004-02-12 | ARIES SELECT I LLC | 446.79K | 0.90% |
| 2004-02-12 | LINDSAY A. ROSENWALD, M.D. | 2.79M | 5.59% |
| 2004-02-12 | PARAMOUNT CAPITAL ASSET MANAGEMENT, INC. | 1.21M | 2.43% |
| 2003-06-13 | (. | 1.66M | 11.00% |
| 2003-02-18 | LINDSAY A. ROSENWALD, M.D.** | 3.16M | 9.66% |
| 2003-02-18 | PARAMOUNT CAPITAL ASSET MANAGEMENT, INC. | 1.55M | 4.73% |
| 2003-02-18 | ARIES DOMESTIC FUND, L.P. | 583.64K | 1.79% |
| 2003-02-18 | ARIES DOMESTIC FUND II, L.P. | 119.37K | 0.37% |
| 2003-02-18 | ARIES MASTER FUND II | 843.39K | 2.58% |
| 2003-02-14 | 84-1474315 | - | 0.00% |
| 2003-02-14 | EIN #75-3019302 | - | 0.00% |
| 2002-02-14 | Lindsay A. Rosenwald, M.D. | 3.52M | 9.90% |
| 2002-02-14 | Paramount Capital Asset Management, Inc. | 1.9M | 5.40% |
| 2002-02-14 | Aries Domestic Fund, L.P. | 510.1K | 1.46% |
| 2002-02-14 | The Aries Domestic Fund II, L.P. | 129.19K | 0.40% |
| 2002-02-14 | The Aries Master Fund II | 1.26M | 3.60% |
| 2002-02-13 | EIN #84-0765359 | 2.52M | 7.50% |
| 2002-02-13 | Thomas H. Bailey | 2.52M | 7.50% |
| 2002-02-13 | EIN #84-1474315 | 1.77M | 5.20% |
| 2002-02-08 | 84-0235630 | - | 0.00% |
| 2001-02-15 | EIN #84-0765359 | 2.78M | 9.50% |
| 2001-02-15 | EIN #84-1474315 | 1.95M | 6.70% |
| 2001-02-15 | Thomas H. Bailey | 2.78M | 9.50% |
| 2001-02-14 | The Aries Master Fund II | 1.78M | 5.90% |
| 2001-02-14 | Paramount Capital Asset Management, Inc. | 2.93M | 9.60% |
| 2001-02-14 | Aries Domestic Fund, L.P. | 859.81K | 2.90% |
| 2001-02-14 | The Aries Domestic Fund II, L.P. | 291.5K | 1.00% |
| 2001-02-14 | Lindsay A. Rosenwald, M.D. | 5.4M | 16.90% |
| 1999-12-21 | The Aries Domestic Fund II, L.P. | 25463.0 | 0.20% |
| 1999-12-21 | Lindsay A. Rosenwald, M.D. | 1.16M | 9.40% |
| 1999-12-21 | Aries Domestic Fund, L.P. | 326.39K | 2.90% |
| 1999-12-21 | Paramount Capital Asset Management, Inc. | 1.16M | 9.40% |
| 1999-12-21 | The Aries Master Fund | 805.56K | 6.80% |
| 1998-02-06 | holding company for Chancellor LGT Asset Management, Inc. | 1.88M | 12.24% |
CTIC Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2022-12-31 | $6.01 | 114.69M | $689.31M | $30.42M | $49.96M | $708.85M |
| 2021-12-31 | $2.48 | 90.12M | $223.49M | $65.45M | $50.56M | $208.6M |
| 2020-12-31 | $3.22 | 71.14M | $229.07M | $40.39M | $5.26M | $193.94M |
| 2019-12-31 | $1.58 | 57.97M | $91.6M | $31.14M | $12.26M | $72.71M |
| 2018-12-31 | $0.73 | 56.07M | $41.14M | $36.44M | $14.08M | $18.78M |
| 2017-12-31 | $2.68 | 36.44M | $97.67M | $27.22M | $14.02M | $84.47M |
| 2016-12-31 | $4.08 | 27.95M | $113.92M | $44M | $19.26M | $89.17M |
| 2015-12-31 | $12.30 | 28.05M | $344.97M | $128.18M | $56.63M | $273.42M |
| 2014-12-31 | $23.60 | 14.85M | $350.53M | $70.93M | $17.38M | $296.98M |
| 2013-12-31 | $19.10 | 11.42M | $218.11M | $71.64M | $13.31M | $159.78M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2023-03-31 | $4.20 | 131.57M | $552.58M | $24.21M | $48.9M | $577.26M |
| 2022-12-31 | $6.01 | 128.43M | $771.84M | $30.42M | $49.96M | $791.38M |
| 2022-09-30 | $5.82 | 121.6M | $707.69M | $32.05M | $49.24M | $724.89M |
| 2022-06-30 | $5.97 | 108.53M | $647.92M | $66.09M | $49.3M | $631.13M |
| 2022-03-31 | $4.67 | 99.83M | $466.22M | $96.9M | $48.34M | $417.67M |
| 2021-12-31 | $2.48 | 97.66M | $242.2M | $65.45M | $50.56M | $227.31M |
| 2021-09-30 | $2.95 | 93.82M | $276.78M | $95.28M | $48.62M | $230.12M |
| 2021-06-30 | $2.50 | 92.34M | $230.85M | $71.88M | $3.99M | $162.96M |
| 2021-03-31 | $2.91 | 76.37M | $222.23M | $33.1M | $5.53M | $194.65M |
| 2020-12-31 | $3.22 | 74.64M | $240.34M | $40.39M | $5.26M | $205.2M |
| 2020-09-30 | $2.15 | 73.71M | $158.48M | $45.3M | $7.04M | $120.22M |
| 2020-06-30 | $1.16 | 73.68M | $85.47M | $70.11M | $8.8M | $24.17M |